Neurotoxin market to reach $12.43 billion by 2030 at 9.1% cagr, driven by surge in cosmetic procedures to improve appearance.
Read More
Neuroregeneration therapy market to reach $20.5 billion by 2030 at 12.6% cagr, driven by rising prevalence of neurological disorders and aging population.
Read More
Neuromuscular blocking drug market to reach $5.23 billion by 2030 at 5.0% cagr, driven by increasing number of surgical procedures.
Read More
The global microcarrier market to reach $4.15 billion by 2030 at 12.0% CAGR, driven by increasing prevalence of cancer cases.
Read More
Neurological Disorder Drugs Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends
Neurological disorder drugs market to reach $116.27 billion by 2030 at 5.3% cagr, driven by increasing prevalence of neurological diseases.
Read More
The global microbiome market to reach $1.64 billion by 2030 at 15.0% CAGR, driven by rising healthcare expenditure.
Read More
Neurogenic detrusor overactivity market to reach $2.63 billion by 2030 at 7.6% cagr, driven by rising incidence of neurological disorders.
Read More
Microbiology technology, equipment and consumables market to reach $13.24 billion by 2030 at 11.3% CAGR, driven by increasing hospital-acquired infection rates.
Read More
Neurodegenerative disorder therapeutics market to reach $34.13 billion by 2030 at 9.6% cagr, driven by increasing investment in research and development.
Read More
Microbial sealant market to reach $4.16 billion by 2030 at 8.1% CAGR, driven by increasing number of surgeries and surging number of sports injuries.
Read More